ÁñÁ«ÊÓƵ

This Viewpoint discusses the 2024 presidential election in the context of the addiction and overdose crisis in the US, which has been a unifying challenge and a source of major ideological division in US politics.

This cohort study analyzes out-of-pocket spending and dispensing of prescription drugs for mental health and substance use disorders after the implementation of a New Mexico law that prohibited cost-sharing for such treatments.

This cohort study examines hospital use and mortality among persons with substance use disorder (SUD) who were released from New Jersey state prisons after a COVID-19 emergency prison release program.

This cross-sectional study evaluates treatment with prescription medications in jails and state prisons relative to noncorrectional settings in the US.

This cohort study evaluates the association between hospitals attesting to an opioid use disorder (OUD) emergency department (ED) treatment pathway and patients’ initiation of buprenorphine treatment.

This cross-sectional study characterizes factors associated with the direct addition of buprenorphine to urine specimens in individuals prescribed buprenorphine for opioid use disorder.

This cohort study examines whether Medicare patients in Wisconsin with opioid use disorder experienced decreased access to opioid use disorder treatment during the COVID-19 pandemic.

This article discusses the public’s spending of the stimulus checks issued by the US government during 2020 and 2021.

This Viewpoint discusses policy changes in regards to mobile methadone clinics and treatment for opioid use disorder.

This cross-sectional study examines trends in the use of buprenorphine among incarcerated individuals in the US.

This study examines COVID-19 cases and deaths among US federal and state prisoners from April 5, 2020, to April 3, 2021, compared with cases and deaths in the overall US population.

This cross-sectional study characterizes factors associated with urine drug positivity for nonprescribed substances among patients prescribed buprenorphine.

This study quantifies the total amount of buprenorphine care delivered by active prescribers and to what extent that varies across specialties.

This cross-sectional study examines the quality of care for conditions other than opioid use disorder in individuals with opioid use disorder.

This cohort study examines changes in the number of buprenorphine prescriptions fill by individuals with opioid use disorder before and during the coronavirus disease 2019 pandemic.

This survey study examines public perception of high priority groups for receipt of an eventual coronavirus disease 2019 vaccine in case of shortage of supply.

This study uses simulated patient calls to a random sample of US residential addiction treatment facilities to investigate the availability of opioid agonist treatment (buprenorphine-naloxone) and nonpharmacologic therapies (eg, CBT) for opioid use disorder, and differences by for-profit vs nonprofit center status.